RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
13.75
+0.69 (5.28%)
At close: May 12, 2025, 4:00 PM
14.00
+0.25 (1.82%)
After-hours: May 12, 2025, 5:53 PM EDT
RxSight Market Cap
RxSight has a market cap or net worth of $558.76 million as of May 12, 2025. Its market cap has decreased by -71.41% in one year.
Market Cap
558.76M
Enterprise Value
341.46M
1-Year Change
-71.41%
Ranking
Category
Stock Price
$13.75
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has increased from $424.33M to $558.76M, an increase of 31.68%. That is a compound annual growth rate of 7.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 530.72M | -61.70% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |